Application of computational methods for anticancer drug discovery, design, and optimization
Developing a novel drug is a complex, risky, expensive and time-consuming venture. It is estimated that the conventional drug discovery process ending with a new medicine ready for the market can take up to 15 years and more than a billion USD. Fortunately, this scenario has recently changed with th...
Main Authors: | Diego Prada-Gracia, Sara Huerta-Yépez, Liliana M. Moreno-Vargas |
---|---|
Format: | Article |
Language: | English |
Published: |
Permanyer
2016-11-01
|
Series: | Boletín Médico del Hospital Infantil de México |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1665114616301411 |
Similar Items
-
Discovery of Monoacylglycerol Lipase (MAGL) Inhibitors Based on a Pharmacophore-Guided Virtual Screening Study
by: Vibhu Jha, et al.
Published: (2021-12-01) -
Targeting Neuronal Transcription Factor BRN2 in Neuroendocrine Tumors
by: Ravi Munuganti, et al.
Published: (2019-08-01) -
Pharmacophore Modeling in Drug Discovery: Methodology and Current Status
by: Muhammed Tilahun MUHAMMED, et al.
Published: (2021-08-01) -
Solution NMR Spectroscopy in Target-Based Drug Discovery
by: Yan Li, et al.
Published: (2017-08-01) -
Computational approaches in target identification and drug discovery
by: Theodora Katsila, et al.
Published: (2016-01-01)